CORRECTION: OnKure Therapeutics Q2 EPS $(0.31) Beats $(0.54) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.54) by 41.51 percent. This is a 72.81 percent increase over losses of $(1.14) per share
OnKure lost less money than Wall Street thought it would—a good sign for a young company still figuring things out. When a company loses less than expected, people often feel a bit more hopeful about where it's heading.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.